Clinical trial
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
NCT00549952 is registered in ClinicalTrials.gov with Korea Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
- Lead sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2007
- Completion date
- March 31, 2008
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oral mucositis